Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT00251498 · COMPLETED
Trial details
- NCT number
- NCT00251498
- Sponsor
- Veeda Oncology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.